StudyRareStudyRare
Log in to add personal notes on this page.

An 18-month-old girl who had been developing normally begins to lose purposeful hand skills and develops stereotypic hand-wringing movements. She loses language and develops breathing abnormalities.

X-linked; MECP2 (methyl-CpG-binding protein 2, Xq28); loss of function.

  • Over 99% simplex, from a de novo variant or parental germline mosaicism; rarely inherited from a mother with minimal findings because of favorable X inactivation
  • Males: severe neonatal encephalopathy (often fatal before age 2 years), PPM-X syndrome (pyramidal signs, parkinsonism, macroorchidism), or intellectual disability; classic Rett syndrome in a male occurs with a 47,XXY karyotype or somatic mosaicism

MeCP2 is a nuclear protein that reads DNA methylation. Its methyl-binding domain attaches to methylated CpG sites in chromatin, and its transcription repression domain recruits the proteins that silence transcription. It also takes part in splicing and long-range chromatin remodeling, and may activate some genes. Loss of MeCP2 leaves chromatin with abnormal epigenetic marks.

Pathogenic variants cause loss of function, and where they fall decides what is lost:

  • Methyl-binding domain (exons 3 and 4): most variants, which stop the protein binding its target DNA.
  • Transcription repression domain and beyond: recurrent nonsense variants, plus frameshifts that delete the C-terminal end.
  • Residual function, milder disease: p.Arg133Cys leaves DNA binding intact and gives milder disease in females; p.Ala140Val gives PPM-X syndrome in males and very mild impairment in females.

Genotype-phenotype correlations are inconsistent because X inactivation varies: a female whose skewing favors the normal X may have mild or no features. Sequence analysis detects 90% to 95% of variants and deletion/duplication analysis 5% to 10%.

  • Normal development until 6-18 months, then regression
  • Loss of purposeful hand use → stereotypic hand movements (wringing, washing)
  • Loss of spoken language
  • Gait abnormalities, acquired microcephaly
  • Breathing abnormalities (hyperventilation, breath-holding)
  • Seizures (6% to 80% across studies)
Rett syndrome
Rett syndrome
  • Clinical diagnosis in girls with a period of normal early development followed by regression, loss of purposeful hand use, stereotypic hand movements, and acquired microcephaly
  • Confirm with molecular testing of MECP2; deletion/duplication analysis if sequencing is negative
  • Consider CDKL5 and FOXG1 in atypical or early-onset (early-seizure or congenital) presentations. CDKL5 deficiency disorder, once called the early-seizure variant of Rett syndrome, is now a separate disorder: seizures begin in the first months of life and cerebral visual impairment is common, and neither is generally seen in classic Rett syndrome
  • Almost always de novo; recurrence risk is low but counsel on rare maternal gonadal mosaicism
  • Multidisciplinary supportive care: physical, occupational, and speech/communication therapy
  • Antiseizure medications for epilepsy; EEG as indicated
  • Cardiology surveillance with ECG for QT prolongation; monitor and manage scoliosis and feeding/GI issues
  • Trofinetide is an approved disease-targeted therapy; otherwise care is symptom-directed

"ReTT": wRinging of hands, Teeter-Totter (broad-based gait), issues with Talking/speech